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The mucosal immune system – consisting of adaptive and innate immune cells as well as the epithe-
lium – is profoundly inﬂuenced by its microbial environment. There is now growing evidence that
the converse is also true, that the immune system shapes the composition of the intestinal microb-
iome. During conditions of health, this bidirectional interaction achieves a homeostasis in which
inappropriate immune responses to non-pathogenic microbes are averted and immune activity sup-
presses blooms of potentially pathogenic microbes (pathobionts). Genetic alteration in immune/epi-
thelial function can affect host gardening of the intestinal microbiome, contributing to the diversity
of intestinal microbiota within a population and in some cases allowing for unfavorable microbial
ecologies (dysbiosis) that confer disease susceptibility.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The small intestine and colon house a complex bacterial ecosys-
tem consisting of an estimated 1014 cells in humans, 10-fold great-
er than the number of human cells [1]. Many have beneﬁcial
functions such as harvesting energy from otherwise indigestible
plant polysaccharides (transferred to the host via short chain fatty
acids), triggering formation of an intestinal mucus barrier, promot-
ing intestinal vascularization, metabolizing xenobiotics, and pre-
venting colonization by pathogens [2–6]. The microbiome also
has profound effects on the immune system, the subject of other
reviews in this issue. The beneﬁcial properties of the intestinal
microbiome confer an evolutionary advantage to animals that
can regulate the microbial communities in their digestive tracts.
Intestinal microbes also beneﬁt from the survival and reproduction
of their hosts. It has been hypothesized that in response to evolu-
tionary pressure favoring mutual survival, hosts and intestinal
microbes have co-evolved traits that foster symbiosis [7,8].The existence of genetically encoded mechanisms for regulating
microbial composition is suggested by the observation that across
mammals, the intestinal microbiome clusters by taxonomic order
rather than geography [9]. This could also reﬂect similarities in
diet, which has been shown across mammals and within human
populations to strongly inﬂuence the intestinal microbiome [10–
12]. However, the microbiome of taxonomic groups such as
bears/pandas with highly variable diets (carnivore, omnivore, her-
bivore) most resembles the microbiome of other members of the
same taxonomic group rather than taxonomically unrelated mam-
mals with a similar diet [9]. An alternate non-genetic explanation
for taxonomic clustering of microbiota is a founder effect due to
initial colonization by microbes of parental origin, allowing for sta-
ble transmission of a species-speciﬁc microbiome without active
host involvement. Human neonates are known to be initially colo-
nized by maternal vaginal or skin bacteria depending on mode of
delivery and founder effects have been demonstrated for speciﬁc
microbes such as Helicobacter pylori [13,14]. However, longitudinal
studies of human infants and ex-germ-free mice have demon-
strated wide ﬂuctuations in microbial community structure – pos-
sibly reﬂecting environmental or stochastic factors – before
Table 1
Genes that have been implicated in microbial gardening in mouse and/or human studies. Targets of microbial gardening are more abundant in KO mice except where noted.
D = depleted, I = mucosal invasion, A = altered abundance that was not further described (or phylotypes within the taxonomic group were both increased and decreased).
Gardening gene Putative microbial targets of gardening Phenotype of knockout mice Disease association (for human
genetic variants)
Pattern recognition receptors
MyD88 [20] Rikenellaceae, Porphyromonadaceae
MyD88, epithelium [21] TM7, Lactobacillus (D), Klebsiella pneumonia (I) Exacerbated DSS colitis
TLR5 [23,25] Escherichia coli (I), Prevotellaceae (A),
Lachnospiraceae (A), Alistipes (A), Bacteroides (A)
bObesity, spontaneous colitis
aTLR2 [26] Alistipes, Lactobacillus, Clostridium, Eubacterium Protection from diet-induced
metabolic syndrome
NOD2 [31–34] Proteobacteria, Bacillus, Clostridium group IV bExacerbated DSS colitis Crohn’s disease, Blau syndrome
aRIP2 [31] bExacerbated DSS colitis
aNLRP6 [38] Prevotellaceae, TM7 bExacerbated DSS colitis
aASC [38] Prevotellaceae, TM7 bExacerbated DSS colitis
aCaspase-1 [38] Prevotellaceae, TM7 bExacerbated DSS colitis
Epithelium
aIL-18 [38] Prevotellaceae, TM7 bExacerbated DSS colitis
Alpha defensins [46] SFB, Bacteroides (D)
ACE2 [48] Limibacter, Paludibacter bExacerbated DSS colitis
Vitamin D receptor [53] Desulfovibrionaceae, Bacteroidaceae,
Erysipelotrichaceae
Exacerbated DSS colitis
Cyp27B1 [53] Desulfovibrionaceae, Bacteroidaceae,
Erysipelotrichaceae
Exacerbated DSS colitis
RegIIIc [22] SFB, Eubacterium rectale Increased intestinal Th1 cells
and IgA production
RELMb [68] Bacteriodetes (A), Firmicutes (A), Proteobacteria (A) Resistance to diet-induced
obesity
FUT2 [77–80] Various (see text) Crohn’s disease, primary sclerosing
cholangitis, psoriasis, type 1 diabetes
Innate lymphoid cells
IL-22 [92,95] SFB, Alcaligenes (I)
aT-bet, with Rag [98,99] Klebsiella pneumonia, Proteus mirabilis, Helicobacter
typhlonius
bSpontaneous colitis
Adaptive immunity
lMT (i.e. no B cells in KO)
[106]
Paracoccus, Lactococcus, Clostridiaceae (D) Lipid malabsorption
AID [107–109] SFB, culturable anaerobes Susceptibility to Y.
enterocolitica
iNOS and TNFa, B cells [110] SFB (D) Susceptibility to C. rodentium
aPD1 [114] Erysipelotrichaceae, Prevotellaceae, Alcaligenaceae,
TM7
Arthritis, glomerulonephritis,
cardiomyopathy
CNS1 [116] TM7, Alistipes Enteritis, gastritis
CD1d [122] SFB, E. coli, Pseudomonas aeruginosa
Other
IRGM [135] Prevotella Crohn’s disease
aSialyltransferase [84] Ruminococcaceae (D) bAttenuated DSS colitis
aApolipoprotein A1 [85] Rikenellaceae, Lachnospiraceae, Erysipelotrichaceae
(D)
Impaired glucose tolerance,
increased body fat
a Denotes genes implicated in gardening by knockout mouse studies that did not use littermate controls from heterozygote breeding.
b Denotes phenotypes that can be attributed to the altered intestinal microbiota based upon co-housing experiments or reconstitution of germ-free mice. SFB = segmented
ﬁlamentous bacteria.
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inﬂuenced by) the founding microbiota [15–17].
Since diet and founder effects, while important, do not alone ex-
plain taxonomic speciﬁcity of microbial composition, it is apparent
that genetically encoded mechanisms exist to ensure that early
ﬂuctuations in intestinal microbiota result in the emergence of a
stable, species-appropriate microbiota. Host factors that could
potentially be utilized to regulate the microbiota include immune
activity, intestinal motility, attachment surfaces, and secreted
products that are metabolized by bacteria. The existence of host
gardening of the intestinal microbiome has largely been probed
by comparing the microbiota of mice deﬁcient in a putative gar-
dening gene to littermate controls using 16S ribosomal RNA
sequencing. The vast majority of gardening genes identiﬁed in this
manner are involved in innate (including epithelial) and adaptive
mucosal immunity (Table 1).2. Microbial sensing via pattern recognition receptors
The immune system is equipped with an intricate system of
germline encoded pattern recognition receptors (PRRs) that recog-
nize microbial molecular patterns. Many of the genes found to af-
fect the microbiome are PRRs, suggesting that gardening is an
active process in which mucosal cells adjust their gardening activ-
ity in response to microbial composition.
2.1. Toll-like receptors (TLRs)
TLRs are transmembrane PRRs that exist either on the cell sur-
face – where they recognize external components of bacteria,
mycoplasma, fungi, and viruses – or in the endolysosomal com-
partment, where they recognize microbial nucleic acids [18]. The
cell surface TLRs include TLR1 (which recognizes lipoproteins),
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TLR6 (lipoproteins). The endolysosomal TLRs include TLR3 (double-
stranded RNA), TLR7 (single stranded RNA), TLR 8 (single stranded
RNA), and TLR9 (unmethylated DNA with CpG repeats). TLR signal-
ing pathways are dependent upon two adaptor molecules, MyD88
(all TLRs except TLR3) and TRIF (TLR3, TLR4). The critical role of
TLRs in recognizing microbial pathogens is revealed by the pheno-
type of MyD88-deﬁcient humans, who develop recurrent pyogenic
bacterial infections [19].
A number of studies have suggested a role for TLRs in immune
gardening of the microbiome. An early study found that MyD88/
mice had increased Rikenellaceae and Porphyromonadaceae in ce-
cal contents [20]. Deletion of MyD88 speciﬁcally in intestinal epi-
thelial cells resulted in increased TM7 and decreased Lactobacillus
in feces [21]. These mice also developed overgrowth of colonic
and ileal mucosa-associated bacteria, which was associated with
invasion of bacteria such as Klebsiella pneumoniae into mesenteric
lymph nodes [21,22]. This indicates that epithelial MyD88-depen-
dent gardening mechanisms exist that modulate microbial compo-
sition and restrain invasive pathobionts. The speciﬁc TLRs involved
are largely unknown, but strong evidence exists that TLR5 has a
gardening effect. TLR5/ mice developed an altered microbiome
which caused spontaneous colitis or, after rederivation into a new
facility, obesity that could be transmitted to co-housed wild-type
mice [23,24]. Obese TLR5/ mice had altered abundance of 116
phylotypes and colitic TLR5/ mice were found to have a bloom
of Enterobacteriaceae, in particular Escherichia coli, penetrating the
colonic mucus layer [25]. This suggests that colitis can be precipi-
tated by deﬁcient gardening of invasive pathobionts. TLR2 has also
been reported to affect microbial composition, with 22 differen-
tially abundant phylotypes in knockout (KO) mice [26].
A recent systematic study of the microbiome in TLR-deﬁcient
mice raised questions about these ﬁndings [27]. No statistically
signiﬁcant differences in microbial composition were observed be-
tween individually caged TLR2, TLR4, TRL5, TLR9, and MyD88 KO
mice compared to littermate controls. The reason for the discrep-
ancy with prior studies is unknown. The earlier TLR2 data may
have been misleading as the TLR2/ and control mice were bred
separately, making it possible that differences in microbial compo-
sition reﬂected environmental factors [26]. However, the earlier
MyD88 and TLR5 studies used heterozygote breeders and the
MyD88 study employed individual caging [20,23]. The lack of ef-
fect of TLR genotype in the recent study may have resulted from
the mice being housed in a facility with autoclaved cages, irradi-
ated food, and acidiﬁed water whereas other studies utilized stan-
dard SPF facilities [27]. This raises the point that gardening, while
genetically encoded, acts on environmental input and so could
potentially be mitigated in a clean environment.2.2. Nod1/2
The NOD-like receptor (NLR) family consists of at least 23 cyto-
plasmic proteins, many with speciﬁcity for bacterial products [28].
The best studied are NOD1, NOD2, and the NLR components of the
inﬂammasome. NOD1 and NOD2 recognize moieties from peptido-
glycan – meso-diaminopimelic acid (DAP) and muramyl dipeptide
(MDP), respectively – which are found on many bacterial and
mycobacterial pathogens. NOD1 is expressed widely while NOD2
is expressed primarily in immune cells and epithelial cells. Follow-
ing microbial sensing, NOD1 and NOD2 translocate to the plasma
membrane and initiate downstream signaling pathways via RIP2
(also known as RICK) [29]. NOD1 and NOD2 are also able to induce
the formation of autophagosomes by recruiting Atg16L1 to the
plasma membrane, resulting in engulfment of invading bacteria
[30].NOD2 has drawn considerable attention due to the strong link
between NOD2 genetic polymorphisms and Crohn’s disease.
NOD2/mice had altered microbial composition in the ileum, co-
lon, and feces as well as an increased number of ileal mucosa-asso-
ciated microbes [31–33]. NOD2/ mice treated with DSS
(dextran sulfate sodium) and AOM (azoxymethane) to induce coli-
tis-associated malignancy had increased colonic Rikenella and Palu-
dibacter compared to controls [31]. The microbiome of NOD2/
and RIP2/ mice conferred susceptibility to DSS colitis that was
transmissible to co-housed wild-type mice [31]. In humans, a
study of the ileal microbiota of normal, colitis, and Crohn’s disease
patients demonstrated that Crohn’s-associated NOD2 polymor-
phisms are associated with altered ileal composition indepen-
dently of disease phenotype [34]. Speciﬁcally, NOD2 was found
to inﬂuence the abundance of Proteobacteria, Bacillus, and Clos-
tridium group IV by 16S sequencing and the Clostridium Coccoides
– Eubacterium Rectales group by quantitative RT-PCR. Human pa-
tients homozygous for NOD2 polymorphisms have increased levels
of both Firmicutes and Bacteroides in ileal tissue, paralleling re-
sults in mice [32].
We are unaware of any studies that have used 16S sequencing
to evaluate the intestinal microbiome in NOD1/ mice, though
one paper using quantitative RT-PCR did not demonstrate any
changes in abundance of a selected panel of bacterial groups [35].
2.3. Inﬂammasome
Inﬂammasomes are cytosolic protein complexes consisting of a
pattern recognition receptor (generally a NLR), the adaptor protein
ASC, and procaspase 1. The primary function of an inﬂammasome
is to cleave caspase 1 into its active form, which can then activate
the inﬂammatory cytokines IL-1b and IL-18 by proteolysis. NLRP1,
NLRP3, NLRP6, and NLRC4 have been documented to form inﬂam-
masomes in response to diverse stimuli including MDP, ﬂagellin,
PrgJ-like proteins from Gram negative bacteria, and reactive oxy-
gen species generated by mitochondrial stress [36,37]. NLRP6 is
found predominantly in epithelial cells, but its ligand remains un-
known [38]. Mice deﬁcient in NLRP6, ASC, or caspase-1 developed
an abnormal microbiota that conferred transmissible susceptibility
to DSS colitis and fatty liver disease [38,39]. These mice were found
to have increased Prevotellaceae and TM7 in feces and expansion of
a crypt base microbe containing electron dense intracellular mate-
rial (a feature seen in some Prevotella). This demonstrates that
intracellular sensing of invasive pathobionts such as Prevotella
by NLRP6 can activate gardening to prevent disease-promoting
dysbiosis. Interestingly, stress was recently shown to downregu-
late NLRP6 via corticotropin-releasing hormone, causing alteration
of the small intestinal microbiome and enteritis that was transmis-
sible to co-housed mice [40].
3. Epithelial gardening
3.1. IL-18
The intestinal epithelium exists in close proximity to the intes-
tinal microbiota and is a likely site of microbial sensing and gar-
dening. The role of the epithelium in gardening is supported by
the phenotype of mice with epithelial speciﬁc MyD88 deletion
and further characterization of NLRP6-mediated gardening [21].
An analysis of IL-1b, IL-1R, and IL-18 KO mice revealed that only
IL-18/ mice had an altered microbiome conferring increased
DSS colitis susceptibility [38]. While the microbiome of IL-18/
mice was not identical to that of NLRP6 and ASC KO mice, it was
characterized by the same increased abundance of Prevotellaceae
and TM7. Bone marrow chimera experiments revealed that IL-18
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dysbiosis, strongly suggesting that the epithelium was the source
of IL-18 processed by the NLRP6 inﬂammasome. The mechanism
of IL-18 gardening is not known but is likely multifactorial as IL-
18 has diverse effects on the immune system including promoting
T helper responses (Th1, Th2, and Th17 depending on the cytokine
milieu), increasing cytotoxic CD8+ T cell activity, activating NK
cells, inducing macrophage inﬂammatory cytokine production,
and recruiting neutrophils [41].
3.2. Antimicrobial products: defensins, cathelicidin, RegIIIc
Intestinal epithelial cells are able to produce a variety of cat-
ionic peptides with broad antimicrobial activity including beta
defensins, alpha defensins, and cathelicidins [42]. Beta defensins
are both constitutively expressed by epithelial cells and induced
by stimuli such as TLR ligands [43]. They act as direct antimicrobial
agents and as chemoattracts for immune cells (including Th17
cells) via CCR6 [42,44]. While beta defensins are attractive candi-
dates to garden the microbiota, this has not yet been studied to
our knowledge. Alpha defensins are expressed by neutrophils
and Paneth cells, a specialized epithelial cell type in the small
intestine that releases granules containing defensins and other
antimicrobial products in response to microbial stimuli [45]. Mice
lacking an enzyme required to process alpha defensins have an al-
tered small intestinal microbiome characterized by reduced Bacte-
roides [46]. Conversely, transgenic expression of an alpha defensin
in Paneth cells resulted in increased Bacteroides and loss of seg-
mented ﬁlamentous bacteria (SFB) colonization in the small intes-
tine. Transgenic mice had fewer Th17 cells in the small intestine,
consistent with reports that intestinal SFB colonization is critical
for induction of Th17 responses in mice [46,47]. Alpha defensin-
mediated gardening may be regulated by the nutrient composition
of the diet. It was recently shown that dietary tryptophan deﬁ-
ciency or deletion of ACE2, an enzyme required for tryptophan
transport into intestinal cells, caused reduced production of anti-
microbial products including alpha defensins [48]. ACE2/ mice
had an altered ileal microbiome (including increased abundance
of several members of the Limibacter and Paludibacter genera)
and increased DSS colitis susceptibility that was transmissible to
germ-free mice. The altered microbiome was reversible by treat-
ment with nicotinamide (a product of tryptophan metabolism) or
treatment with a dipeptide form of tryptophan which could be ab-
sorbed without ACE2.
Cathelicidin in its active peptide form, LL-37, has broad antimi-
crobial activity and acts as a chemoattract for neutrophils, mono-
cytes, and T cells via the formyl peptide receptor-like 1 [42,49].
Expression of cathelicidin by epithelial cells and innate immune
cells can be induced by short chain fatty acids derived from bacte-
rial metabolism and by vitamin D [50–52]. Indeed, vitamin D deﬁ-
ciency resulting in inadequate cathelicidin production has been
proposed as a mechanism of tuberculosis susceptibility in dark-
skinned populations [52]. While we are unaware of any direct
studies on microbial composition in cathelicidin deﬁcient mice,
one study has evaluated the microbiome of mice deﬁcient in vita-
min D receptor and Cyp27B1 (the enzyme that generates the active
form of vitamin D, 1,25-dihydroxycholecalciferol) [53]. These mice
had an altered microbiome characterized at the family level by
higher abundance of Desulfovibrionaceae, Bacteroidaceae, and
Erysipelotrichaceae and lower abundance of Lactobacillaceae,
Lachnospiraceae, Ruminococcaceae, Streptococcaceae, and Defer-
ribacteraceae. Intestinal expression of Cyp27B1 has recently been
shown to be regulated by the microbiota, suggesting that vitamin
Dmediated gardening is modulated by PRR signaling [54]. Interest-
ingly, deﬁciency of vitamin D receptor (VDR) or Cyp27B1 exacer-
bates DSS colitis [55,56]. This can be rescued byepithelial-speciﬁc transgenic expression of VDR, demonstrating
the physiologic importance of vitamin D signaling for epithelial
homeostasis [57]. However, vitamin D can enhance tight junctions
and is involved in many immune processes including T cell homing
to the intestine, maintenance of intraepithelial T lymphocytes, and
development of natural killer T cells, so it is unclear if the microbial
phenotype of these mice or their susceptibility to colitis is due to
reduced cathelicidin expression [56,58–60].
Paneth cells and enterocytes also secrete RegIIIc, an antimicro-
bial lectin produced predominantly in the ileum that has preferen-
tial activity against Gram positive bacteria [61]. It is minimally
expressed in germ-free mice but rapidly induced upon convention-
alization. This likely occurs through TLR-mediated microbial sens-
ing by epithelial cells, as epithelial cell speciﬁc deletion of MyD88
greatly reduces RegIIIc [22]. Loss of RegIIIc expression after antibi-
otic treatment allowed for expansion of an antibiotic-resistant
Gram positive pathogen, vancomycin-resistant Enterococcus [62].
RegIIIc/ mice have been found to have increased mucosa-asso-
ciated microbiota in the ileum, characterized by overgrowth of at
least two groups of Gram positive organisms – segmented ﬁlamen-
tous bacteria (SFB) and E. rectale [22]. This corresponded to in-
creased Th1 activity and IgA production in the small intestine,
suggesting that the altered microbiome provoked adaptive im-
mune responses. Increased intestinal Th17 activity was not ob-
served in RegIIIc/ mice, but systemic Th17 responses were
not assessed [22].
3.3. RELMb
Intestinal goblet cells are capable of secreting not only mucus
but also bioactive molecules including RELMb, a product speciﬁc
to goblet cells that is upregulated during inﬂammatory processes
and parasite infection [63–65]. RELMb is undetectable in germ-free
mice but is induced within 48 h of conventionalization, indicating
that its expression is controlled by microbial factors [66]. It stimu-
lates macrophages to secrete inﬂammatory cytokines including
TNFa and IL-12, which then promotes IFNc production by T cells
[63,67]. KO mice show reduced DSS colitis severity, impaired re-
sponses to helminths, and resistance to diet induced obesity
[63,65,67,68]. These mice were found to have an altered microbi-
ome characterized by differential abundance of 15 Bacteriodetes,
15 Firmicutes, and 1 Proteobacteria lineages, indicating that
RELMb has a gardening effect [68]. However, it is unknown
whether the phenotypes of these mice were due to alteration of
the intestinal microbiota.
3.4. FUT2
Epithelial gardening involves not only antimicrobial and immu-
nomodulatory molecules but also mucus glycoproteins, which
serve as attachment sites and energy sources for microbes. Consid-
erable evidence now exists that the intestinal microbiome is inﬂu-
enced by fucosylation – the addition of L-fucose to the terminal b-
D-galactose residue of mucus glycoproteins by a1–2 fucosyltrans-
ferase (encoded by the FUT2 gene). Fucose is utilized as a nutrient
source by some bacteria, most notably B. thetaiotaomicron, and can
be scavenged by pathogens such as E. coli and Salmonella typhimu-
rium early during infection [69–71]. Some intestinal microbes uti-
lize fucose to synthesize capsular polysaccharides [72]. In addition,
the H antigen created by FUT2 has been shown to serve as an
attachment site by pathogens such as norovirus and Campylobacter
jejuni [73,74]. Fucosylation is a microbiota-dependent process. In
germ-free mice, fucosylation occurs immediately after birth but
is lost over time [75]. Fucosylation was restored by conventionali-
zation or colonization with B. thetaiotaomicron, which expresses an
unidentiﬁed product in response to low fucose levels that induces
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feces had increased abundance of Parabacteroides, Eubacterium,
Parasutterella, Bacteroides, and Lachnospiraceae and decreased
abundance of an unclassiﬁed Clostridiales genus in their feces
[77]. Interestingly, the microbiome of FUT2/mice fed a polysac-
charide-deﬁcient diet was unchanged from controls, demonstrat-
ing the interplay that exists between diet and host gardening. In
humans, deﬁciency of FUT2 – which occurs in around 20% of indi-
viduals, termed ‘‘non-secretors’’ – was associated with shifts in
microbial composition in the colonic mucosa (increased Coprococ-
cus and an unclassiﬁed Lachnospiraceae), feces (reduced Biﬁdobac-
teria), and bile (reduced Proteobacteria) [78–80]. The altered
intestinal microbiome in non-secretors is suspected to account
for their increased risk for inﬂammatory/autoimmune diseases
including Crohn’s disease, primary sclerosing cholangitis, psoriasis,
and type 1 diabetes [80–83].
FUT2 is not the only reported example of non-immune genetic
gardening. Sialyltransferase is an enzyme that synthesizes sialyl-
lactose in milk, which may act as a nutrient source for some mi-
crobes and affect bacterial adhesion. In its absence, knockout and
WT co-fostered mice developed an altered microbiome character-
ized by decreased susceptibility to DSS colitis [84]. Apolipoprotein
A1 is a component of high-density lipoprotein. Knockout mice have
features of metabolic syndrome, in particular impaired glucose tol-
erance, and alterations in microbial composition [85]. In addition,
other glycosylation enzymes besides FUT2 involved in mucus for-
mation may also affect microbial composition. For instance, deﬁ-
ciency of enzymes necessary for the synthesis of core 1, core 2,
and core 3 O-glycans present in mucus have been reported to in-
crease DSS colitis susceptibility or induce a microbiota-dependent
spontaneous colitis [86–88]. It is not yet known if these pheno-
types were related to alterations in microbial composition, but this
is a plausible mechanism.4. Innate lymphoid cells (ILCs)
In recent years, groups of cells have been characterized that
resemble subsets of T cells but lack a rearranged antigen receptor.
These innate lymphoid cells include natural killer (NK) cells,
GATA3-dependent cells with a Th2-like cytokine proﬁle, and
RORct-dependent cells [89]. RORct-dependent ILCs are the pri-
mary intestinal source of IL-22, a cytokine induced by IL-23 which
is critical for epithelial production of antimicrobial proteins includ-
ing RegIIIb, RegIIIc, S100A8, and S100A9 [90–92]. Mice lacking ILCs
have minimal RegIIIc expression by the intestinal epithelium
[90,93]. IL-22 production appears to be regulated by the microbiota
in a manner that depends on the route of exposure to microbial li-
gands. Colonization of germ-free mice reduced IL-22 production by
ILCs, possibly via induction of epithelial IL-25 by microbial prod-
ucts [90]. In contrast, systemic administration of a bacterial prod-
uct, ﬂagellin, increased IL-22 production by triggering IL-23 release
from CD103+ DCs via TLR5 [94].
The ability of ILCs to regulate antimicrobial production by epi-
thelial cells has made them an attractive candidate gardening cell
type in the mucosa. Indeed, antibody-mediated depletion of ILCs
and anti-IL-22 treatment resulted in increased SFB levels in the
feces [95]. It has not yet been reported whether ILCs inﬂuence
the composition of the remainder of the microbiome in the intes-
tinal lumen. ILC depletion and anti-IL-22 treatment has also been
found to permit systemic dissemination of Alcaligenes xylosoxidi-
ans, an invasive Proteobacteria species that normally is contained
to mouse Peyer’s patches and mesenteric lymph nodes [92]. This
suggests that in addition to gardening luminal SFB, possibly via
regulation of IL-22, ILCs also guard against invasive species that
have penetrated the epithelial barrier.A subset of RORct-dependent ILCs has recently been described
that expresses T-bet, lacks CCR6 expression, and differentiates into
NKp46+ RORct-dependent ILCs [96]. These cells are reduced in
number in germ-free mice. A similar reduction is seen in
MyD88/TRIF/ mice, suggesting that TLR signaling controls
this population. IFNc-producing T-bet + CCR6-RORct-dependent
ILCs played a critical role in the intestinal response to Salmonella
and may also be involved in microbial gardening. This ILC subset
is absent in Rag/Tbet/mice, which develop an altered micro-
biota causing transmissible colitis [97,98]. These mice had differ-
ential abundance of 69 phylotypes in feces by 16S sequencing
and increased abundance of K. pneumoniae and Proteus mirabilis
(both Proteobacteria) by culture [99]. It was subsequently discov-
ered that the colitis phenotype was attributable to colonization
with Helicobacter typhlonius [98]. This invasive Proteobacteria trig-
gered a response by an IL-17-producing CCR6+ subset of RORct-
dependent ILCs, previously shown to mediate colitis induced by
Helicobacter hepaticus [98,100]. Of note, the emergence of a colito-
genic microbiota in Rag/Tbet/ mice was initially attributed
to increased production of TNFa by dendritic cells (DCs) although
it now appears to be most likely due to a deﬁcit in T-bet-dependent
ILCs [97]. Current evidence argues against a role for DCs in garden-
ing, as mice deﬁcient in the two CD103+ lamina propria DC popu-
lations had no alteration in intestinal microbiota [98]. However,
the CD103CD11b+ DC subset which expresses TNFa in
Rag/Tbet/ mice has not been studied [101].5. Adaptive immune cells
5.1. B cells
Evidence for a role of the adaptive immune system in microbial
gardening has come largely from studies of B cells. Intestinal B cells
are present in the lamina propria, isolated lymphoid follicles (ILF),
and Peyer’s patches (PP). They develop into IgA-producing plasma
cells after undergoing class switching and afﬁnity maturation in a
T-cell-dependent manner in PP germinal centers or a T-cell-inde-
pendent manner in ILFs and the lamina propria [102,103]. This
process requires activation-induced cytidine deaminase (AID) and
microbial triggers. Germ-free mice have few IgA-secreting intesti-
nal B cells despite normal numbers of B cells [104]. IgA is rapidly
induced upon bacterial colonization and persists even after disap-
pearance of bacteria from the gut, suggesting that IgA-secreting B
cells are imprinted by microbial exposure rather than requiring
ongoing stimulation [105].
Mice deﬁcient in all B cells were found to have alterations in the
jejunal microbiome including increased Paracoccus, increased Lac-
tococcus, and decreased Clostridiaceae [106]. The absence of non-
IgM antibodies and somatic hypermutation due to AID deﬁciency
caused increased culturable anaerobes and SFB in the small intes-
tine [107,108]. This could be reversed by surgically connecting the
circulatory system of AID knockouts to wild-type mice, indicating
that serum factors (presumably immunoglobins) mediated the
phenotype [108]. Similar microbial changes were observed in
Rag/ mice (i.e. T and B cell deﬁcient), which could be reversed
by bone marrow transplantation from WT but not AID/ mice.
The importance of somatic hypermutation in IgA gardening was re-
cently shown using AID knock-in mice carrying a mutation that al-
lowed for normal class switching but disrupted somatic
hypermutation [109]. These mice had alterations in their small
intestinal microbiome characterized by increased culturable anaer-
obes and increased abundance of Lachnospiraceae, Bacteroidales,
and Lactobacillus. Recently, a population of small intestinal IgA-
producing plasma cells was discovered that expresses inducible ni-
tric oxide synthase (iNOS) and TNFa in a microbiota-dependent
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cells resulted in deﬁciency of IgA-producing cells in the lamina
propria. Interestingly, this was accompanied by reduced small
intestinal SFB, suggesting that B cells can garden in a TNFa/iNOS-
dependent manner that favors SFB.
5.2. T cells
T cells, in particular T follicular helper (TFH) cells, have been
implicated in microbial gardening through their regulation of B cell
class switching and afﬁnity maturation in PP germinal centers
[111]. TFH cells have characteristically high expression of the inhib-
itory receptor, programmed cell death-1 (PD1). In the absence of
PD1, mice develop antibody-mediated arthritis, glomerulonephri-
tis, and cardiomyopathy [112,113]. PD1/ mice also have an al-
tered microbiome, including increased culturable anaerobic
bacteria in the small intestine and increased Erysipelotrichaceae,
Prevotellaceae, Alcaligenaceae, and TM7 in the cecum [114]. This
was attributed to poor afﬁnity maturation of the IgA repertoire
due to aberrant B cell selection in PP germinal centers [115]. Pos-
sible additional evidence for T cell regulation of B-cell-mediated
gardening comes from a study of mice lacking TGFb-induced
FoxP3-expressing regulatory T cells due to CNS1 deﬁciency. These
mice had increased numbers of germinal center B cells and pro-
duced autoantibodies reacting against intestinal antigens [116].
They developed a B-cell-mediated enteritis characterized by plas-
ma cell expansion and Th2 cytokine expression. These mice had in-
creased TM7 and Alistipes in their feces. However, it is unclear if
this was due to altered gardening (perhaps secondary to height-
ened B cell activity) or was a secondary consequence of intestinal
inﬂammation.
5.3. CD1d-restricted T cells
Natural killer T (NKT) cells are a class of T cells that express NK
markers and respond to lipid antigens presented by CD1d as well
as to cytokine stimulation by IL-12, IL-18, and type 1 interferons
[117]. They have potent effector activity through their release of
cytokines including IFNc, IL-4, IL-17, and TNFa. A subset of these
cells, termed invariant NKT (iNKT) cells, has a restricted TCR reper-
toire and has been shown to be strongly regulated by microbial sig-
nals. In germ-free mice, iNKTs are increased in the colonic lamina
propria in a CXCL16 dependent manner but decreased in the liver
and spleen, which could be reversed by colonization with Sphingo-
monas (which expresses ligands recognized by iNKT cells) [118–
120]. iNKTs respond to a wide range of pathogens and may also
be involved in gardening [121]. One study of CD1d/ mice ob-
served alterations in the fecal microbiota, increased ileal SFB, and
increased small intestinal colonization by pathogens including
E. coli and Pseudomonas aeruginosa [122]. NKTs may be involved
in gardening downstream of NLRP6 and IL-18, but this has not
yet been evaluated.
5.4. cd intraepithelial lymphocytes (IELs)
A diverse collection of T cells reside within the intestinal epithe-
lium, of which about 60% express TCRcd. This IEL subset secretes
growth factors that promote epithelial growth/repair and can com-
bat enteric pathogens through IFNc production and direct cytotoxic
activity [123]. After epithelial injury, cd IELs prevent mucosal pene-
tration of bacteria by secreting growth factors, chemokines, and
antimicrobial products in a partially MyD88-dependent manner
[124]. cd IELsmay also play a role in gardening invasive pathobionts
in the absenceof epithelial injury. Colonizationof germ-freemice in-
duces expression of antimicrobials by cd IELs including RegIIIc and
RegIIIb [125]. This could be reproduced by colonizationwith a singleendogenous mucosa-invasive E. coli species or wild-type Salmonella
(but not a non-invasive mutant), suggesting that cd T cells respond
to microbes that penetrate the mucus barrier. Absence of cd T cells
resulted in an inability to control new invasive species early after
exposure. WT mice co-housed with TCRcd/ mice showed in-
creased RegIIIc expression by cd T IELs, suggesting that these mice
were exposed to mucosa invasive bacteria which arose in TCRcd/
mice due to deﬁcient gardening. However, it has not yet been di-
rectly demonstrated to our knowledge that loss of cd T cells alters
the composition of the microbiome.6. Inter-individual variation in microbial composition due to
genetic variation in gardening
The existence of multiple mechanisms for gardening the intes-
tinal microbiome raises the possibility that variation in gardening
genes can contribute to microbial diversity within populations.
This has been supported by multiple mouse studies. Comparison
of 8 inbred strains revealed that each had a distinct microbial
composition which was not eliminated by cohabitation, though
founder effects could not be excluded [126]. Two quantitative
trait loci (QTL) analyses of interbred mouse lines have identiﬁed
multiple genetic factors inﬂuencing the abundance of microbes
at various taxonomic levels [127,128]. The ﬁrst study identiﬁed
thirteen QTLs affecting microbial composition, including one
mapping to a region containing IL-22, IFNc, and Irak3 (an inhib-
itor of TLR signaling) that affected Lactococcus and Coriobacteria-
ceae abundance [127]. The second study identiﬁed ﬁve QTLs, of
which three contained candidate genes affecting immune activity
(consistent with the immune system playing a major role in gar-
dening) [128]. This included type 1 interferons, Irak4 (a signaling
molecule utilized by some TLRs), and Tgfb3, which inﬂuenced the
abundance of Bacteroides, Rikenellaceae, and Prevotellaceae,
respectively. Host genetics can also interact with diet, as was
shown in a study reporting wide variation among 52 strains of
mice in the effect of a high-fat, high-sucrose diet on the microb-
iome [129]. The authors identiﬁed a single nucleotide polymor-
phism (SNP) near 3 amylase genes which was associated with
enrichment of Enterobacteriaceae on a high fat, high-sucrose diet.
In humans, twin studies have been used to evaluate the global
impact of genetic variation on microbial composition. The intesti-
nal microbiome has consistently been shown to be more similar
between pairs of monozygotic twins than between pairs of unre-
lated individuals [130–134]. However, monozygotic twins share
many environmental factors including maternal colonizers, early
life environment, and childhood diet. This can be controlled by
comparing monozygotic twins to dizygotic twins. Signiﬁcantly in-
creased microbial similarity between monozygotic twins com-
pared to dizygotic twins has been reported in two studies using
the Sorensen index to analyze data from 16S Sanger sequencing
and temporal temperature gradient gel electrophoresis [130,133].
In contrast, two studies using high throughput 16S sequencing
and a phylogenetic similarity measure, Unifrac, reported no differ-
ence in microbial similarity between monozygotic twins compared
to dizygotic twins [131,132]. However, even if this is correct, the
global similarity analysis used in these studies may not reveal
shifts in the abundance of speciﬁc microbial groups due to genetic
variation.
This review has already mentioned two genes, FUT2 and NOD2,
with genetic variants that affect microbial composition [34,78–80].
Recently, a microbiome association study using 30 Crohn’s associ-
ated SNPs identiﬁed a genetic variant, the rs11747270a SNP, that
correlates with Prevotella abundance in sigmoid colon biopsies
[135]. This SNP maps to the locus for immunity-related GTPase
family M (IRGM) [136]. This protein regulates autophagy, a process
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intracellular bacteria including Salmonella, Mycobacterium, and
invasive E. coli [137]. A second Crohn’s associated IRGM polymor-
phism has been reported to reduce the effectiveness of autophagy
in response to intracellular bacteria [138]. Interestingly, Prevotella
species including P. intermedia and P. bivia have been reported to
invade epithelial cell lines [139,140]. It is conceivable that the ele-
vated abundance of Prevotella in colonic biopsies was due to in-
creased survival of invasive organisms due to deﬁcient IRGM
activity. As further genome wide association studies are performed
for microbial composition, it is likely that many additional exam-
ples of genetic polymorphism in gardening genes will be identiﬁed
in human populations.
7. Acquired immune deﬁcits can inﬂuence the microbiota
The critical role of mucosal immunity in shaping the intestinal
microbiome suggests that not only genetic but also acquired deﬁ-
cits in immune function could affect the microbiota. A common
cause of acquired immunodeﬁciency in humans in recent decades
has been HIV. It is now appreciated that HIV transmission, replica-
tion, and persistence occur largely in mucosal tissues [141]. Rapid
depletion of mucosal memory CD4+ T cells occurs during acute
infection and is sustained throughout the chronic phase of disease
[142]. This is accompanied by a decrease in the ratio of Th17:Tregs,
increased CD8+ T cells, and decreased NK cells. As a consequence of
these immune disturbances, HIV patients have increased epithelial
permeability, systemic microbial translocation, and elevated ser-
um inﬂammatory markers consistent with a chronic inﬂammatory
state [143]. In most patients, these mucosal immune disturbances
are not reversed completely by highly active anti-retroviral ther-
apy [144]. In light of changes in mucosal immunity induced by
HIV, it has been predicted that HIV infection would impact the
intestinal microbiome. A longitudinal study of chimpanzees beforeFig. 1. Putative mechanisms for immune gand after SIV infection observed increased abundance of Sarcina,
Staphylococcus, and Selenomonas in the feces [145]. Three recent
papers evaluating the mucosal and fecal microbiome of untreated
and treated HIV patients have conﬁrmed altered microbial com-
munities in HIV [146–148]. All three identiﬁed a reduction in
Alistepes and two identiﬁed a reduction in Bacteroides. However,
they each reported enrichment of different microbial groups in
HIV patients. One identiﬁed enrichment of multiple members of
the Proteobacteria phylum (including pathobionts such as Pseudo-
monas), another Prevotella, and the third Fusobacterium (a genus
which includes pathobionts that can invade epithelial cells)
[149]. The discrepancies may reﬂect different sampling sites in
each of the studies or stochastic overgrowth of pathobionts in
the face of disrupted immune gardening.
Acquired deﬁcits in immune function can also be seen in pa-
tients treated with immunosuppressive medication to prevent
rejection of solid organ transplants. While we are not aware of
published reports on the intestinal microbiome of this population,
at least one study has examined the oral microbiome. Transplant
patients were found to have altered microbial composition includ-
ing increased abundance of pathobionts such as Klebsiella, Aceni-
tobacter, and Pseudomonas [150]. More broadly, medications that
affect the immune system – such as immunomodulators and biol-
ogics (not including antibiotics) used to treat inﬂammatory bowel
disease, rheumatic diseases, and psoriasis – could also potentially
affect microbial gardening and result in disease-promoting dysbio-
sis. There is minimal data at present on this topic, though the exis-
tence of medication-speciﬁc microbial proﬁles was suggested in
the oral microbiome study and one of the HIV studies [148,150].
8. Conclusion
There is now extensive evidence that genetically encoded
mechanisms exist for gardening the intestinal microbiome. Theseardening of the intestinal microbiome.
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mechanisms such as defensins, RegIIIc, and IgA (Fig. 1). However,
many questions remain. At present, the gardening activity of spe-
ciﬁc PRRs has been characterized in terms of shifts at the genus
or higher taxonomic level in knockout mice. It is unknown what
changes occur at the species or strain level, whether PRRs have
overlapping activity, and which microbial features trigger garden-
ing pathways dependent upon a single PRR (e.g. NLRP6-mediated
gardening of Prevotella, which was unaffected by loss of any other
inﬂammasome-forming NLR) [38]. The effector mechanisms that
allow for targeted gardening of speciﬁc microbes are also unknown
(other than IgA), as host antimicrobial products generally have a
wide spectrum of activity. While many immune cell types have
been implicated in gardening, the relationships between each im-
mune cell type and speciﬁc microbial taxa are largely uncharacter-
ized with exceptions such as SFB gardening by B cells and NK T
cells.
Despite the many unknowns, it is clear that gardening of the
intestinal microbiome is critical for health. In many studies, dis-
ruption of gardening resulted in dysbiosis which conferred suscep-
tibility to diseases including colitis, obesity, and fatty liver disease.
This often corresponded to a bloom of pathobionts, especially Pro-
teobacteria such as E. coli in TLR5/mice, Prevotella in NLRP6/
mice, Helicobacter in Rag/Tbet/ mice, and Alcaligenes in ILC-
deﬁcient mice. The three human genetic variants associated with
gardening are all also risk factors for Crohn’s disease, possibly
due to dysbiosis. Gardening can be affected not only by genetic
variation but also by diet (as shown for tryptophan/defensins),
stress (as shown for NLRP6), and acquired immune deﬁcits (includ-
ing, potentially, due to immunosuppresive medication). Disease-
promoting dysbiosis arising from aberrant microbial gardening
could prove to be a common theme in medicine.References
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